+86 137 2013 4139
+86 137 2013 4139
| CAS: | 1210344-83-4 | Cat No: | JKN00695 | Purity: | 98% |
Note: All products of the company are for scientific research only, and do not provide products and services for any individual
Product Description
| CAS | 1210344-83-4 | Cat No | JKN00695 | |
| Name | Ertugliflozin pidolate | |||
| Synonyms | 1210344-83-4 | |||
| Smiles | CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl.C1CC(=O)N[C@@H]1C(=O)O | |||
| Chemical Name | (1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol;(2S)-5-oxopyrrolidine-2-carboxylic acid | |||
| Formula | C27H32ClNO10 | MWt | 566.0 | |
| Purity | 98% | Storage | Store at 4--8℃ | |
| Description | ERTUGLIFLOZIN PIDOLATE is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for type 2 diabetes mellitus. | |||
Product Documents
Menu
Contact Us
Tel: +86 137 2013 4139
E-mail: orders@jknbiochem.com
Add.:Room 2120, Office Building 2, No.1 Baisha Fifth Road, Hongshan District, Wuhan City, Hubei Province, China
Get In Touch
Get In Touch
